A new multi-pronged antibody design could help immune cells receive stronger activation signals against cancer. Researchers ...

A new approach to strengthening the immune system's fight against cancer is showing potential. Researchers at the University ...

Researchers at the University of Southampton have developed a promising new way to bolster the body's immune system response ...

Researchers at the University of Southampton engineered four-pronged antibodies that cluster the CD27 immune receptor, ...

Researchers at the University of Southampton have developed a promising new way to bolster the body's immune system response to cancer.In a study ...

A phase I, first-in-human study of ARGX-110, a monoclonal antibody targeting CD70, a receptor involved in immune escape and tumor growth in patients with solid and hematologic malignancies. This is an ...

HAMPTON, N.J., Aug. 24, 2020 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (Nasdaq:CLDX) announced today that enrollment has opened in its open-label, Phase 1 study of CDX-527 in patients with ...

Correlation of immune response with clinical outcomes in melanoma patients receiving adjuvant therapy of pegylated interferon alpha-2b combined with gp100 peptide vaccine. Phase 2 open-label study of ...

Researchers at the University of Southampton have developed a new antibody design that boosts the immune system’s ability to fight cancer by enhancing activation of T cells through the CD27 receptor.

γδTcells have been preserved alongside αβ T cells and B cells over the last ∼450 million years of vertebrate evolution 1, and are increasingly recognized as having important roles in immune responses ...

Levels of CD27 in the cerebral spinal fluid (CSF) could be used as a potential clinical biomarker to help in treatment decisions after a first demyelinating attack to help gauge which patients will go ...